Thromb Haemost 1998; 80(05): 763-766
DOI: 10.1055/s-0037-1615355
Review Article
Schattauer GmbH

Factor V Leiden and Prothrombin Gene G 20210 A Variant in Children with Ischemic Stroke

Authors

  • W. Zenz

    1   From the Department of Pediatrics, University of Graz
    2   From the Ludwig Boltzmann Institute for Pediatric Thrombosis and Hemostasis, Graz
  • Z. Bodó

    1   From the Department of Pediatrics, University of Graz
  • Jutta Plotho

    1   From the Department of Pediatrics, University of Graz
  • W. Streif

    3   From the Department of Pediatrics, University of Innsbruck
  • Ch. Male

    4   From the Department of Pediatrics, University of Vienna
  • G. Bernert

    4   From the Department of Pediatrics, University of Vienna
  • L. Rauter

    5   From the Department of Pediatrics, Landeskrankenhaus Leoben
  • G. Ebetsberger

    6   From the Landeskinderklinik Linz
  • K. Kaltenbrunner

    7   From the Department of Pediatrics, Landeskrankenhaus Villach
  • P. Kurnik

    8   From the Department of Pediatrics, Landeskrankenhaus Klagenfurt
  • A. Lischka

    9   From the Kinderklinik der Stadt Wien-Glanzing
  • F. Paky

    10   From the Department of Pediatrics, Landeskrankenhaus Mödling
  • R. Ploier

    11   From the Department of Pediatrics, Landeskrankenhaus Steyr
  • G. Höfler

    12   From the Department of Pathology, University of Graz
  • Christine Mannhalter

    13   From the Department of Laboratory Medicine, University of Vienna, Austria
  • W. Muntean

    1   From the Department of Pediatrics, University of Graz
    2   From the Ludwig Boltzmann Institute for Pediatric Thrombosis and Hemostasis, Graz
Further Information

Publication History

Received 23 February 1998

Accepted after resubmission 24 July 1998

Publication Date:
07 December 2017 (online)

Preview

Summary

Objective: To investigate if the factor V Leiden mutation (F-V-LM) and/or the prothrombin gene G 20210 A variant (P-G20210A-V) are risk factors for acute stroke in Austrian children. Patients: 33 children with acute ischemic stroke documented by computer tomography and/or magnetic resonance imaging of the brain were enrolled in an open multicenter survey. Results: 6/33 children had F-V-LM (5 heterozygous, 1 homozygous). This represents 18% (95% CI: 6.7-39.9%) of our pediatric stroke population and thus exceeds the expected prevalence in the Austrian population of 4,6% (Fischer’s exact test, p = 0.01). F-V-LM was not found in 11 children with neonatal stroke but in 6/22 children with stroke after the neonatal period. 5/6 children with F-V-LM had an underlying disorder that is a risk factor for stroke in children. The P-G20210A-V was detected in 1/26 (3.85%; 95% CI: 0.1-21.4%) patients. Comparison of the prevalence of P-G20210A-V in our study with that in the general population of Austria of 1% revealed no statistical significance (Fischer’s exact test, p = 0.38). Conclusion: Our data suggest that the F-V-LM is a risk factor for acute stroke in Austrian children beyond the neonatal period. The P-G20210A-V apparently does not represent a risk factor for stroke in Austrian children.